Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits

J. Roy Chowdhury, Mariann Grossman, Sanjeev Gupta, N. Roy Chowdhury, James R. Baker, James M. Wilson

Research output: Contribution to journalArticle

309 Scopus citations


Familial hypercholesterolemia (FH) is an inherited disorder in humans that is caused by a deficiency of low density lipoprotein receptors (LDLRs). An animal model for FH, the Watanabe Heritable Hyperlipidemic rabbit, was used to develop an approach for liver-directed gene therapy based on transplantation of autologous hepatocytes that were genetically corrected ex vivo with recombinant retroviruses. Animals transplanted with LDLR-transduced autologous hepatocytes demonstrated a 30 to 50 percent decrease in total serum cholesterol that persisted for the duration of the experiment (122 days). Recombinant-derived LDLR RNA was harvested from tissues with no diminution for up to 6.5 months after transplantation.

Original languageEnglish (US)
Pages (from-to)1802-1805
Number of pages4
Issue number5039
StatePublished - Jan 1 1991


ASJC Scopus subject areas

  • General

Cite this